Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A P Haynes

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|November 18, 1998
Adjuvant alpha-interferon improves complete remission rates following allogeneic transplantation for multiple myelomaJ L Byrne, G I Carter, N Bienz, et al.
Bone Marrow Transplantation|October 6, 1997
Autologous GVHD following PBSCT, with evidence for a graft-versus-myeloma effectJ L Byrne, G I Carter, I Ellis, et al.
British Journal of Haematology|March 21, 2008
IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphomaC P Fox, A K McMillan, M J Bishton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefitI G McQuaker, A E Hunter, S Pacey, et al.
Clinical and Diagnostic Laboratory Immunology|September 8, 1998
Role of arachidonic acid and its metabolites in the priming of NADPH oxidase in human polymorphonuclear leukocytes by peritoneal dialysis effluentI Daniels, M A Lindsay, C I Keany, et al.
British Journal of Haematology|December 3, 1999
Comparative serial quantitative measurements of chimaerism following unmanipulated allogeneic transplantation of peripheral blood stem cells and bone marrowG Miflin, C J Stainer, G I Carter, et al.
British Journal of Haematology|February 26, 2000
Induction of remission after donor leucocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: evidence for a 'graft vs. myelofibrosis' effectJ L Byrne, H Beshti, D Clark, et al.
Bone Marrow Transplantation|October 3, 1998
Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxisJ L Byrne, C Stainer, H Hyde, et al.
Bone Marrow Transplantation|June 28, 2005
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantationN H Russell, J L Byrne, R D Faulkner, et al.
British Journal of Haematology|December 19, 1998
A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical courseJ L Byrne, G I Carter, J M Davies, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|November 18, 1998
Adjuvant alpha-interferon improves complete remission rates following allogeneic transplantation for multiple myelomaJ L Byrne, G I Carter, N Bienz, et al.
Bone Marrow Transplantation|October 6, 1997
Autologous GVHD following PBSCT, with evidence for a graft-versus-myeloma effectJ L Byrne, G I Carter, I Ellis, et al.
British Journal of Haematology|March 21, 2008
IVE (ifosfamide, epirubicin and etoposide) is a more effective stem cell mobilisation regimen than ICE (ifosphamide, carboplatin and etoposide) in the context of salvage therapy for lymphomaC P Fox, A K McMillan, M J Bishton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Low-dose filgrastim significantly enhances neutrophil recovery following autologous peripheral-blood stem-cell transplantation in patients with lymphoproliferative disorders: evidence for clinical and economic benefitI G McQuaker, A E Hunter, S Pacey, et al.
Clinical and Diagnostic Laboratory Immunology|September 8, 1998
Role of arachidonic acid and its metabolites in the priming of NADPH oxidase in human polymorphonuclear leukocytes by peritoneal dialysis effluentI Daniels, M A Lindsay, C I Keany, et al.
British Journal of Haematology|December 3, 1999
Comparative serial quantitative measurements of chimaerism following unmanipulated allogeneic transplantation of peripheral blood stem cells and bone marrowG Miflin, C J Stainer, G I Carter, et al.
British Journal of Haematology|February 26, 2000
Induction of remission after donor leucocyte infusion for the treatment of relapsed chronic idiopathic myelofibrosis following allogeneic transplantation: evidence for a 'graft vs. myelofibrosis' effectJ L Byrne, H Beshti, D Clark, et al.
Bone Marrow Transplantation|October 3, 1998
Low incidence of acute graft-versus-host disease and recurrent leukaemia in patients undergoing allogeneic haemopoietic stem cell transplantation from sibling donors with methotrexate and dose-monitored cyclosporin A prophylaxisJ L Byrne, C Stainer, H Hyde, et al.
Bone Marrow Transplantation|June 28, 2005
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantationN H Russell, J L Byrne, R D Faulkner, et al.
British Journal of Haematology|December 19, 1998
A novel BCR-ABL fusion gene (e2/1a) in a patient with Philadelphia-positive chronic myelogenous leukaemia and an aggressive clinical courseJ L Byrne, G I Carter, J M Davies, et al.
Pageof 5